Skip to main content

Surgical Robotics Market is anticipated to grow with a robust CAGR of 10.2% between 2021-2031

 Surgical robotic systems primarily include surgical systems (capital equipment), instruments & accessories, and services (maintenance and up-gradation). In the past decade, the definition of these advanced technologies has expanded, involving the use of these systems for multiple surgical procedures ranging from general surgeries to orthopedic surgeries. The ongoing trend of rising demand for surgical robotic systems is anticipated to continue in the future with the implementation of technological innovations and advancements in minimally invasive surgical procedures.

Owing to the rapid technological advances in the field of surgical robotics and its increasing adoption across different healthcare facilities, as depicted in the preceding figure, the overall market size is anticipated to grow at the CAGR of 10.2% during the forecast period 2021-2031. The surgical systems segment is anticipated to generate a value of $16,774.5 million in 2031.



Market Segmentation • Product Type: Surgical Systems, Instruments & Accessories, and Services • Application: General Surgery, Urology Surgery, Gynecology Surgery, Orthopedic Surgery, Cardiology Surgery, Head & Neck Surgery, and Others • End-User: Hospitals, Ambulatory Surgical Centers, and Specialty Clinics Regional Segmentation • North America: U.S. and Canada • Europe: Germany, U.K, France, Italy, Spain, Turkey, Russia, Belgium, Switzerland, Sweden, Netherlands, Denmark, Norway, Finland, Austria, Ireland, Rest-of-Europe • Asia-Pacific: Japan, China, India, South Korea, Australia & New Zealand, Taiwan, Thailand, Malaysia, Singapore, Indonesia, and Philippines • Latin America: Brazil, Mexico, Argentina, chile, Venezuela, Colombia, Puerto Rico, Panama, and Uruguay • Rest-of-the-World: Kingdom of Saudi Arabia, Israel, Qatar, Pakistan, Kuwait, Egypt, and Lebanon Growth Drivers • Rising Incidence of Chronic Disorders Inciting the Use of Robotic-Assisted Surgical Procedures • Elevating Geriatric Population Changing the Adoption Patten for Minimally Invasive Surgical Procedures • Rising Demand of Minimally Invasive Surgical Procedures Signifies the Need for Robotic-Assisted Surgeries • Technological Advancement in the Field of Medical Surgeries Market Challenges • High Cost of Surgical Robotic Systems and its Associated Procedures • Shortage of Skilled Professionals • Restrictive Reimbursement Landscape Market Opportunities • Development of Low-Cost Surgical Robotic Systems • Implementation of Artificial Intelligence (AI) in Surgical Robots • Development of Surgical Simulators for the Training of Professionals Market Trends • Operating Lease Programs Implemented by the Surgical Robotic Manufacturers Key Companies Profiled Asensus Surgical, Inc., avatera medical GmbH, CMR Surgical Limited, Corin Group, Curexo, Inc., Globus Medical, Inc., Intuitive Surgical, Inc., Johnson & Johnson, Medicaroid Corporation, Medrobotics Corporation, Medtronic plc, meerecompany, Inc., Monteris Medical Corporation, Neocis, Inc., PROCEPT BioRobotics Corporation, Renishaw plc, Siemens Healthineers AG, Smith & Nephew plc, Stereotaxis, Inc., Stryker Corporation, THINK Surgical, Inc., Titan Medical, Inc., Venus Concept, Inc., Vicarious Surgical, Inc., Virtual Incision Corporation, and Zimmer Biomet Holdings, Inc.

Request a Sample-https://bisresearch.com/requestsample?id=1110&type=download

Comments

Popular posts from this blog

Microbiome Therapeutics Market Growth, Segmentation, Opportunity and Forecast to 2032

  Global microbiome therapeutics market is expected to grow further in the coming years due to the continuous increase in awareness and need for better and safer treatment alternatives and the dominance of gastrointestinal (GI) and infectious diseases segment can be attributed to the existing dominance of microbiome therapeutics available for a variety of indications ranging from diarrhea and gut dysbiosis to skin disorders, cancer indications among others. The global microbiome therapeutics market which accounted for $306.3 million in 2021 is expected to reach $3,204 million by 2032, reporting a CAGR of 24.95% during the forecast period 2022-2032. The existing   microbiome therapeutics market    is favored by multiple factors, including the rising geriatric populations coupled with the increasing adoption of inorganic growth strategies by key players in the market. Impact of COVID-19 There were numerous consequences due to the COVID-19 pandemic, especially...

Digital PCR Market size,Share, Leading Players, Growth, Development and Demand Forecast to 2032

  Increasing investments in R&D for d-PCR molecular diagnostics is one of the major opportunities in the global digital PCR market. Several biotechnology and life sciences companies are working collaboratively on diagnostic test development and using d-PCR as a therapeutic means for applications in several disease indications to enable efficient diagnosis, treatment selection, and treatment monitoring. The global  digital PCR market   is projected to reach $2,847.8 million by 2032 from $441.2 million in 2021, at a CAGR of 18.73% during the forecast period 2022–2032. The growth in the global digital PCR market is expected to be driven by factors such as the increasing prevalence of infectious and genetic diseases globally, the rising awareness of d-PCR-based diagnostic testing, and the significant number of funding for executing research and development. Impact of COVID-19 The current global digital PCR market comprises kits and assays, system, and reagents and consuma...

Radiation Dose Management Market Likely To Increase Size, Shares, And Demand Forecast 2022-2032

  Radiation dose is the amount of radiation absorbed by a patient during a diagnostic imaging procedure. A large dose of radiation can cause tissue damage and increase the risk of developing cancer in later stages of life.The development of on-cloud dose management solutions and the growing initiatives on radiation dose management for pediatric procedures are some of the major opportunities in the global radiation dose management market. Furthermore, some of the key trends going on in the market include the increasing development of imaging modalities with technologies that lower radiation dose, partnerships and strategic business alliances dominating the market, and various collaborations among market players. The global  radiation dose management market   was valued at $212.8 million in 2021 and is anticipated to reach $586.7 million by 2032, witnessing a CAGR of 10.30% during the forecast period 2022–2032. The growth in the global radiation dose management market is ex...